Double Medical Technology Inc.
Sembol: 002901.SZ
SHZ
31.91
CNYBugünkü piyasa fiyatı
214.6551
F/K Oranı
0.2706
PEG Oranı
13.21B
MRK Kapağı
- 0.00%
DIV Verimi
Double Medical Technology Inc. (002901-SZ) Finansal Tablolar
Bilanço
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1661 | 1351.3 | 1179.9 | |||||||||||
balance-sheet.row.short-term-investments | 0 | 433.2 | 358.7 | 769.7 | |||||||||||
balance-sheet.row.net-receivables | 0 | 274.3 | 374.5 | 498.1 | |||||||||||
balance-sheet.row.inventory | 0 | 1193.3 | 987.4 | 670.2 | |||||||||||
balance-sheet.row.other-current-assets | 0 | 26.7 | 13 | 46.9 | |||||||||||
balance-sheet.row.total-current-assets | 0 | 3155.3 | 2726.2 | 2395.1 | |||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 1070.9 | 877.7 | 698.7 | |||||||||||
balance-sheet.row.goodwill | 0 | 68.3 | 69.1 | 69.7 | |||||||||||
balance-sheet.row.intangible-assets | 0 | 136.9 | 143.2 | 148.6 | |||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 205.2 | 212.3 | 218.3 | |||||||||||
balance-sheet.row.long-term-investments | 0 | 138.9 | 0 | -768.4 | |||||||||||
balance-sheet.row.tax-assets | 0 | 8.9 | 7.2 | 8.3 | |||||||||||
balance-sheet.row.other-non-current-assets | 0 | 60.6 | 114.3 | 827.9 | |||||||||||
balance-sheet.row.total-non-current-assets | 0 | 1484.4 | 1211.4 | 984.8 | |||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.total-assets | 0 | 4639.7 | 3937.6 | 3379.9 | |||||||||||
balance-sheet.row.account-payables | 0 | 281.6 | 345.4 | 296.3 | |||||||||||
balance-sheet.row.short-term-debt | 0 | 328 | 7.7 | 5 | |||||||||||
balance-sheet.row.tax-payables | 0 | 4.9 | 31.9 | 99.1 | |||||||||||
balance-sheet.row.long-term-debt-total | 0 | 261.3 | 60.9 | 13.6 | |||||||||||
Deferred Revenue Non Current | 0 | 50.1 | 48.7 | 48.5 | |||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||
balance-sheet.row.other-current-liab | 0 | 372.1 | 226.6 | 7.4 | |||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 275.3 | 114.3 | 69.7 | |||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 10.9 | 12.9 | 13.6 | |||||||||||
balance-sheet.row.total-liab | 0 | 1429 | 830.9 | 791.5 | |||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.common-stock | 0 | 414 | 414 | 405.1 | |||||||||||
balance-sheet.row.retained-earnings | 0 | 1275.9 | 1217.3 | 1333.5 | |||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 400.6 | 400.8 | 224.1 | |||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 968 | 968 | 549.7 | |||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 3058.5 | 3000.1 | 2512.5 | |||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 4639.7 | 3937.6 | 3379.9 | |||||||||||
balance-sheet.row.minority-interest | 0 | 102.2 | 106.7 | 75.9 | |||||||||||
balance-sheet.row.total-equity | 0 | 3160.7 | 3106.8 | 2588.4 | |||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||
Total Investments | 0 | 433.2 | 358.7 | 1.3 | |||||||||||
balance-sheet.row.total-debt | 0 | 600.2 | 68.6 | 18.6 | |||||||||||
balance-sheet.row.net-debt | 0 | -627.6 | -924.1 | -391.5 |
Nakit Akış Tablosu
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 59 | 109.2 | 691.5 | |||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 194.4 | 95.5 | 70.9 | |||||||||||
cash-flows.row.deferred-income-tax | 0 | -3.8 | -1.7 | -3.9 | |||||||||||
cash-flows.row.stock-based-compensation | 0 | -606 | 109.6 | 32.8 | |||||||||||
cash-flows.row.change-in-working-capital | 0 | -217.2 | -195 | -134.4 | |||||||||||
cash-flows.row.account-receivables | 0 | 86.8 | 121.9 | -179.4 | |||||||||||
cash-flows.row.inventory | 0 | -422.2 | -418.3 | -140.4 | |||||||||||
cash-flows.row.account-payables | 0 | 118.1 | 103.1 | 189.3 | |||||||||||
cash-flows.row.other-working-capital | 0 | 0 | -1.7 | -3.9 | |||||||||||
cash-flows.row.other-non-cash-items | 0 | 659.5 | 10.8 | 16.3 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -305.7 | -285.1 | -235.1 | |||||||||||
cash-flows.row.acquisitions-net | 0 | 1.6 | -0.3 | -88 | |||||||||||
cash-flows.row.purchases-of-investments | 0 | -2240.4 | -4523.7 | -6977.8 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 2024.6 | 4992.5 | 6723.4 | |||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | -409 | 180.8 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -519.9 | -225.6 | -396.8 | |||||||||||
cash-flows.row.debt-repayment | 0 | -530.5 | -0.7 | -8.3 | |||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 487.5 | 76.3 | |||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -75.7 | -2.9 | |||||||||||
cash-flows.row.dividends-paid | 0 | -9.4 | -209.4 | -324.1 | |||||||||||
cash-flows.row.other-financing-activites | 0 | -24 | 43.4 | -0.3 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 496.2 | 245.2 | -259.3 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 1.1 | 4.3 | -3.6 | |||||||||||
cash-flows.row.net-change-in-cash | 0 | 235.2 | 152.3 | 13.6 | |||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 1227.8 | 214.1 | 61.8 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 992.7 | 61.8 | 48.1 | |||||||||||
cash-flows.row.operating-cash-flow | 0 | 85.8 | 128.4 | 673.3 | |||||||||||
cash-flows.row.capital-expenditure | 0 | -305.7 | -285.1 | -235.1 | |||||||||||
cash-flows.row.free-cash-flow | 0 | -219.9 | -156.6 | 438.2 |
Gelir Tablosu Satırı
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1518.8 | 1434.1 | 1994.3 | |||||||||||
income-statement-row.row.cost-of-revenue | 0 | 527.8 | 333.9 | 311.1 | |||||||||||
income-statement-row.row.gross-profit | 0 | 991 | 1100.2 | 1683.3 | |||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||
income-statement-row.row.other-expenses | 0 | -43.9 | 25.7 | 19.8 | |||||||||||
income-statement-row.row.operating-expenses | 0 | 983.2 | 984.2 | 865.3 | |||||||||||
income-statement-row.row.cost-and-expenses | 0 | 1511 | 1318.1 | 1176.3 | |||||||||||
income-statement-row.row.interest-income | 0 | 29.9 | 21 | 14.4 | |||||||||||
income-statement-row.row.interest-expense | 0 | 7.2 | 3.1 | 0.5 | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 91.9 | 0 | -19.5 | |||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||
income-statement-row.row.other-operating-expenses | 0 | -43.9 | 25.7 | 19.8 | |||||||||||
income-statement-row.row.total-operating-expenses | 0 | 91.9 | 0 | -19.5 | |||||||||||
income-statement-row.row.interest-expense | 0 | 7.2 | 3.1 | 0.5 | |||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 194.4 | 108.6 | 75.9 | |||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||
income-statement-row.row.operating-income | 0 | 7.8 | 147.5 | 822 | |||||||||||
income-statement-row.row.income-before-tax | 0 | 99.7 | 147.5 | 802.5 | |||||||||||
income-statement-row.row.income-tax-expense | 0 | 13.4 | 38.2 | 111 | |||||||||||
income-statement-row.row.net-income | 0 | 59 | 92.6 | 673.3 |
Sıkça Sorulan Sorular
Nedir Double Medical Technology Inc. (002901.SZ) toplam varlıklar?
Double Medical Technology Inc. (002901.SZ) toplam varlıklar 4639740860.000 şeklindedir.
İşletmenin yıllık geliri nedir?
Yıllık gelir N/A'dur.
Firma kâr marjı nedir?
Firma kar marjı 0.667'dir.
Şirket serbest nakit akışı nedir?
Serbest nakit akışı -0.212'dur.
İşletme net kar marjı nedir?
Net kâr marjı 0.040'dir.
Firma toplam geliri nedir?
Toplam gelir 0.042'dur.
Nedir Double Medical Technology Inc. (002901.SZ) net kar (net gelir)?
Net kar (net gelir) 58972461.000'dur.
Firmanın toplam borcu nedir?
Toplam borç 600196725.000'dir.
Faaliyet giderleri rakamı nedir?
İşletme giderleri 983165028.000'dır.
Şirket nakit rakamı nedir?
İşletme içi nakit 0.000'tir.